JP2023530457A5 - - Google Patents

Info

Publication number
JP2023530457A5
JP2023530457A5 JP2022577587A JP2022577587A JP2023530457A5 JP 2023530457 A5 JP2023530457 A5 JP 2023530457A5 JP 2022577587 A JP2022577587 A JP 2022577587A JP 2022577587 A JP2022577587 A JP 2022577587A JP 2023530457 A5 JP2023530457 A5 JP 2023530457A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022577587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023530457A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/037714 external-priority patent/WO2021257754A1/en
Publication of JP2023530457A publication Critical patent/JP2023530457A/ja
Publication of JP2023530457A5 publication Critical patent/JP2023530457A5/ja
Pending legal-status Critical Current

Links

JP2022577587A 2020-06-16 2021-06-16 小分子ve-ptp阻害剤 Pending JP2023530457A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063039764P 2020-06-16 2020-06-16
US63/039,764 2020-06-16
PCT/US2021/037714 WO2021257754A1 (en) 2020-06-16 2021-06-16 Small molecule ve-ptp inhibitors

Publications (2)

Publication Number Publication Date
JP2023530457A JP2023530457A (ja) 2023-07-18
JP2023530457A5 true JP2023530457A5 (enExample) 2024-06-28

Family

ID=79268399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022577587A Pending JP2023530457A (ja) 2020-06-16 2021-06-16 小分子ve-ptp阻害剤

Country Status (6)

Country Link
EP (1) EP4164690A1 (enExample)
JP (1) JP2023530457A (enExample)
CN (1) CN117460743A (enExample)
AU (1) AU2021292526A1 (enExample)
CA (1) CA3182748A1 (enExample)
WO (1) WO2021257754A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795444B2 (en) * 2006-06-27 2010-09-14 Warner Chilcott Company Human protein tyrosine phosphatase inhibitors and methods of use
US9096555B2 (en) * 2009-01-12 2015-08-04 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome
ES2726946T3 (es) * 2009-07-06 2019-10-10 Aerpio Therapeutics Inc Derivados de benzosulfonamida, composiciones de los mismos y su uso en la prevención de la metástasis de las células cancerosas
GB2516561B (en) * 2013-03-15 2016-03-09 Aerpio Therapeutics Inc Compositions, formulations and methods for treating ocular diseases

Similar Documents

Publication Publication Date Title
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2021169491A5 (enExample)
JP2022068302A5 (enExample)
JP2021028398A5 (enExample)
JP2023116721A5 (enExample)
JP2021038271A5 (enExample)
JP2024023385A5 (enExample)
JP2023022224A5 (enExample)
JP2021184963A5 (enExample)
JP2020042034A5 (enExample)
JP2020127428A5 (enExample)
JP2022523200A5 (enExample)
JP2024016014A5 (enExample)
JP2021518389A5 (enExample)
JP2023100643A5 (enExample)
JP2022060295A5 (enExample)
JP2025506484A5 (enExample)
JP2022537813A5 (enExample)
JP2020171301A5 (enExample)
JP2020120660A5 (enExample)
JP2021524864A5 (enExample)
JP2022022379A5 (enExample)
JP2023085551A5 (enExample)